Live: Will Credo Keep Rallying After Q4 Earnings Tonight?

That wraps up our initial coverage of Credo’s Q4 earnings results. Thank you for stopping by!

One of the most impressive parts of Credo’s quarter wa the profitability. The company posted a non-GAAP gross margin of 68.3% and generated $226.7 million in non-GAAP net income during the quarter. This was well above guidance of 64-66%.

Many hardware companies sacrifice margins to grow quickly. Credo is doing the opposite. The combination of triple-digit revenue growth and software-like profitability helps explain why investors continue to assign the stock a premium valuation.

Credo’s growth story continues to impress. FY2026 revenue soared 206% to $1.34 billion, while quarterly revenue climbed 157% year over year to a record $437 million.

The company remains one of the clearest beneficiaries of the AI infrastructure buildout, with strong demand for its high-speed connectivity products helping power increasingly larger GPU clusters.

Revenue guidance of $465-$475 million for next quarter suggests the momentum isn’t slowing down.

Credo just reported earnings with shares initially down 12% following the report. Here are the key numbers:

• Revenue: $437.0M vs. $433.3M expected
• Adjusted EPS: $1.16 vs. $1.03 expected

Quick read:

• Credo delivered another clean beat, extending its streak of outperforming Wall Street expectations as AI networking demand remains strong.
• Revenue surged 157% year over year, and EPS jumped 231%, showing that growth remains exceptional even as the company scales toward a multi-billion-dollar revenue run rate.

Beyond the obvious bar of beating consensus, several under-discussed wildcards could swing tonight’s reaction for Credo Technology Group (NASDAQ:CRDO).

Four Wildcards Not Fully Priced In

• Margin step-down already telegraphed: Q4 non-GAAP gross margin guidance of 64.0%-66.0% vs 68.6% in Q3 as ZeroFlap optics, Active Line Cards, and OmniConnect ramp.
• Insider selling intensity: 123 disposals and zero purchases since March, including the CTO unloading shares at prices up to $190.50.
• Inventory swell: $207.9M, up from $26M two years earlier: bullish pre-build or potential write-down risk.
• Valuation tension: Shares at $234.12 sit above the $211.86 analyst target, with a P/E near 130. Any tariff or export-control headline lands on a stretched setup.

Watch commentary on hyperscaler order timing and TensorWave traction for diversification signals.

With Credo’s earnings call expected tonigth at 5 PM ET, here are some top questions analysts might be thinking about ahead of the call.

Top 5 Questions Analysts Will Press

• Customer concentration: revenue mix beyond the top hyperscaler, plus TensorWave ramp pace.
• Gross margin recovery timeline after the guided step-down to 64.0%-66.0%.
• FY2027 framework: ZeroFlap, Active Line Cards, OmniConnect revenue cadence.
• 1.6T product design wins and AEC inflection.
• Competitive positioning versus Marvell and Broadcom.

Buzzwords to Listen For

“Hyperscaler,” “design wins,” “AEC inflection,” “sequential growth,” “customer diversification,” “energy-efficient connectivity”.

Red Flags

• Any softening of the $425M-$435M revenue range.
• Inventory or receivables climbing again.
• Vague answers on hyperscaler order timing, given net insider selling across the C-suite.

Insider activity over the past 90 days shows 123 disposals, zero purchases, with no dollars on the buy side. CTO Cheng led with 95 sales, concentrated when shares hit $184–$190.

The CEO, CFO, and COO also moved in lockstep on April 2 and April 5 at a uniform $101.45, suggesting 10b5-1 plans. The May 19 CLO sale, days ahead of the earnings blackout, stands out.

One-way selling at peak prices signals executives are de-risking, even as retail sentiment scores 85.

With Credo Technology (NASDAQ:CRDO) reporting after the close, here’s the distilled bull versus bear setup heading into tonight’s earnings report.

Bull Case

• Beat streak intact: Four straight quarters of EPS beats ranging +13.75% to +44.20%.
• Operating leverage: Q3 non-GAAP operating margin hit 49.6% on revenue of $407.01M (+201.5% YoY).
• TAM expansions: ZeroFlap optics, ALCs, and OmniConnect open three multi-billion-dollar markets atop surging hyperscaler AEC demand.

Bear Case

• Stretched multiple: P/E of 130 with shares at $231.84, above the $211.86 analyst target.
• Reaction risk: Day-of moves on prior beats have swung from -14.81% to +14.8%.
• Insiders out: 124 recent transactions, net selling.

Tonight’s Q1 FY27 guide will likely decide which side wins.

Credo (NASDAQ:CRDO) has beaten its own revenue guidance every quarter, most recently delivering $407.01M against a midpoint near $260M, so the bar for the initial Q1 FY2027 outlook is high.

Wall Street wants four data points:

1. Q1 FY2027 revenue guide above $460M
2. Non-GAAP gross margin stabilizing at or above 66%
3. Commentary on the ZeroFlap Optics ramp pulled forward to Q1 FY’27
4. Progress diversifying beyond the 39% top-customer concentration.

Bearish scenario: Guidance near $420M–$440M with margins below 64% would signal deceleration against a 129 P/E.

Management typically guides conservatively, so the tone of the conference call on 2027’s outlook will likely move the stock more than the headline numbers.

Beyond the obvious bar of beating estimates, here are 4 under-discussed wildcards that could swing tonight’s reaction for Credo Technology Group (NASDAQ:CRDO).

• Margin step-down already telegraphed: Q4 non-GAAP gross margin guidance of 64.0%-66.0% vs 68.6% in Q3 as ZeroFlap optics, Active Line Cards, and OmniConnect ramp.
• Insider selling intensity: 123 disposals and zero purchases since March, including the CTO unloading shares at prices up to $190.50.
• Inventory swell: $207.9M, up from $26M two years earlier: bullish pre-build or potential write-down risk.
• Valuation tension: Shares at $234.12 sit above the $211.86 analyst target, with a P/E near 130. Any tariff or export-control headline lands on a stretched setup.

Investors should also watch commentary on hyperscaler order timing and TensorWave traction.

Credo enters earnings after beating EPS estimates in four straight quarters, and investors are expecting another strong performance.

The focus tonight is on whether management can deliver at the high end of guidance, maintain strong margins, and support the extraordinary growth that has taken quarterly revenue from roughly $50 million to nearly $400 million in just two years.

Any sign of slowing momentum could quickly put pressure on the stock’s premium valuation.